減価償却費 - メディカルテクノロジー、Transfer From Other Components Of Equity To Retained EarningsSSIFRS、子会社の売却による収入他1件
- 【期間】
| 年度 | 減価償却費 - メディカルテクノロジー | Transfer From Other Components Of Equity To Retained EarningsSSIFRS | 子会社の売却による収入 | 未収消費税等 |
|---|
| 2009/03 | - | | - | | - | | 32.9億 | |
| 2010/03 | - | | - | | - | | 30.9億 | -6.2% |
| 2011/03 | - | | - | | - | | 29.2億 | -5.3% |
| 2012/03 | - | | - | | - | | 20.2億 | -30.7% |
| 2013/03 | - | | - | | - | | 28.4億 | +40.1% |
| 2014/03 | - | | - | | - | | 30.9億 | +9% |
| 2015/03 | - | | - | | - | | 9.31億 | -69.9% |
| 2016/03 | - | | - | | - | | 17.2億 | +85% |
| 2017/03 | - | | - | | - | | 25.9億 | +50.6% |
| 2017/12 | 7.74億 | | - | | - | | 41億 | +58% |
| 2018/12 | 11億 | +42.4% | - | | - | | 37.4億 | -8.8% |
| 2019/12 | - | | - | | 698百万 | | 30.2億 | -19.3% |
| 2020/12 | - | | - | | - | | 27.6億 | -8.7% |
| 2021/12 | - | | - | | - | | 15.7億 | -43.1% |
| 2022/12 | - | | - | | - | | 15.7億 | -0.1% |
| 2023/12 | - | | - | | - | | 12.3億 | -21.5% |
